Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Likelihood ratio analysis of the radiologic flow chart to discriminate different types of cerebellar tumors
Diagnosis Flow Chart Sequence LR+ (95% CI) LR– (95% CI)
AT/RT 411/311 34 (10.6–109)^{^a} 0.26 (0.1–0.7)
Ependymoma 323/423 16.5 (7.9–35) 0.11 (0.03–0.4)^{^a}
Medulloblastoma SHH 111/112/313 10.6 (5.2–21.7) 0.3 (0.1–0.7)
Medulloblastoma group 3 or 4 312 10.07 (5.3–19.3) 0.23 (0.12–0.45)^{^a}
Pilocytic astrocytoma 123 20 (7.7–52.8) 0.13 (0.13–0.26)^{^a}
↵a Clinically applicable confidence intervals.

Diagnosis	Flow Chart Sequence	LR+ (95% CI)	LR– (95% CI)
AT/RT	411/311	34 (10.6–109)^{^a}	0.26 (0.1–0.7)
Ependymoma	323/423	16.5 (7.9–35)	0.11 (0.03–0.4)^{^a}
Medulloblastoma SHH	111/112/313	10.6 (5.2–21.7)	0.3 (0.1–0.7)
Medulloblastoma group 3 or 4	312	10.07 (5.3–19.3)	0.23 (0.12–0.45)^{^a}
Pilocytic astrocytoma	123	20 (7.7–52.8)	0.13 (0.13–0.26)^{^a}